Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegfilgrastim versus filgrastim for PBPC mobilization and engraftment in multiple myeloma autologous transplantation
2006-000891-34Phase 2Completed
- Sponsor
- Hôpital Ambroise-Paré
- Start
- Mar 2006
- Modality
- Recombinant Proteins and Enzymes, Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of pegfilgrastim and filgrastim in multiple myeloma (MM) (3 arms), sponsored by Hôpital Ambroise-Paré. Started Mar 2006; status: completed.
02
Drugs
pegfilgrastimfilgrastim
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2006-000891-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000891-34.